The United States government has said it would provide up to $11 million dollars to support the packaging of Bavarian Nordic’s Jynneos Monkeypox Vaccine at a U.S based manufacturer’s facility.
According to the U.S Department of Health and Human Services, the production is expected to begin later this year, and the funding will help the manufacturer to recruit more staff and buy additional equipment.
Tell me more…
The Danish company, which is the maker of the only approved Monkeypox Vaccine signed up Michigan-based Grand River Aseptic Manufacturing to package the two-dose shot.
The Jynneos Vaccine is in short supply and U.S regulators have authorized a method of administration that allows providers to get five doses instead of one from a single vial to expand access.
The United States initially ordered three million doses and in July sought another 2.5 million doses, but Bavarian Nordic said the additional doses would be packaged at the U.S facility.